Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-102 in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer
NCT03762161Phase 2Unknown
- Start
- Jan 2019
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in bladder cancer. Status: unknown.
02
Drugs
trifluridine + tipiracil
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT03762161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03762161.